CoChat

Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis

Open access

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Cigarette smoking has been associated with the risk of idiopathic pulmonary fibrosis (IPF). Certain comorbidities have been associated with reduced survival although some studies have indicated that current smokers have a longer survival than ex-smokers. Comorbidities in relation to smoking history have not been previously analyzed. METHODS: Retrospective data was collected and patients were categorized according to gender and smoking habits. Comorbidities and medications were collected. Predictive values for mortality were identified by COX proportional hazard analyses. RESULTS: We examined 45 non-smokers (53.3% female), 66 ex-smokers (9.1% female) and 17 current smokers (17.6% female) with IPF. Current smokers were younger at baseline (58.1 ± 8.74 years) compared to non-smokers (71.4 ± 8.74, p < 0.001) and ex-smokers (72.5 ±7.95, p <0.001). Median survival of non-smokers and current smokers was longer (55.0 and 52.0 months, respectively) than that of ex-smokers (36.0 months) (p=0.028 and 0.034, respectively). In age and severity adjusted analyses, smoking was not related to survival. Cardiovascular diseases (CVD) (72.7 %) were the most common comorbidities, current smokers had more chronic obstructive pulmonary disease (COPD) and lung cancer compared to ex-smokers (p<0.001). CVD, COPD and use of insulin were related to poorer survival in adjusted analyses. CONCLUSIONS: Smoking seems to influence the course of disease in IPF since current smokers developed the disease at a younger age in comparison to non-smokers and ex-smokers. No significant differences in the major comorbidities were detected between IPF patients with different smoking histories. The mechanism through which smoking influences IPF progression requires further investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12931-017-0642-6

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Analyses of survival indicates that ex-smokers revealed shorter survival time (36 months) than current smokers (52 months (0.029)) or non-smokers (55 months (p=0.034))
Fig. 1 Analyses of survival indicates that ex-smokers revealed shorter survival time (36 months) than current smokers (52 months (0.029)) or non-smokers (55 months (p=0.034))CC BY · PubMed Central
Fig. 2 Prevalence of comorbidities in the IPF patients are presented as percent of total (N=132). The time of comorbidity diagnoses are presented before and after the diagnosis of IPF. CVD includes CAD, HT and CI. B, diagnosed before the diagnosis of IPF; A, diagnosed after the diagnosis of IPF; CVD, cardiovascular disease; CAD, coronary artery disease; HT, hypertension; DM, diabetes; HF, heart failure for any reason; GER, gastro-esophageal reflux; COPD, chronic obstructive pulmonary disease; CI, cerebral infarction; TIA, transient ischemic attack; OSA, obstructive sleep apnea. Other cancers treated before the diagnosis of IPF included seminoma, melanoma, basal cell carcinoma, renal, ventricular, prostate, bone, colorectal, breast and thyroid cancer. One patient had three different cancers. Two colorectal cancers were detected after the diagnosis of IPF
Fig. 2 Prevalence of comorbidities in the IPF patients are presented as percent of total (N=132). The time of comorbidity diagnoses are presented before and after the diagnosis of IPF. CVD includes CAD, HT and CI. B, diagnosed before the diagnosis of IPF; A, diagnosed after the diagnosis of IPF; CVD, cardiovascular disease; CAD, coronary artery disease; HT, hypertension; DM, diabetes; HF, heart failure for any reason; GER, gastro-esophageal reflux; COPD, chronic obstructive pulmonary disease; CI, cerebral infarction; TIA, transient ischemic attack; OSA, obstructive sleep apnea. Other cancers treated before the diagnosis of IPF included seminoma, melanoma, basal cell carcinoma, renal, ventricular, prostate, bone, colorectal, breast and thyroid cancer. One patient had three different cancers. Two colorectal cancers were detected after the diagnosis of IPFCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 76

Metadata

Authors
Kärkkäinen, M., Kettunen, H.-P., Nurmi, H., Selander, T., Purokivi, M., & Kaarteenaho, R.
Affiliations
  • University of Eastern Finland (FI)
  • Kuopio University Hospital (FI)
Corresponding author
Kärkkäinen, Miia
Venue
Respiratory Research
Published
2017-08-22
Volume
18
Issue
1
Pages
160-160
ISSN
  • 1465-9921 (ISSN-L)
  • 1465-993X
OpenAlex
W2745939486
Cited by
72
References
29
Citations by year
2026: 3 · 2025: 8 · 2024: 8 · 2023: 5 · 2022: 13 · 2021: 10 · 2020: 9 · 2019: 12 · 2018: 3 · 2017: 1
FWCI
5.66
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Respiratory Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • The Foundation of The Finnish Anti-Tuberculosis Association
  • The Organization for Respiratory Health in Finland
  • the Väinö and Laina Kivi Foundation
  • The Kuopio Region Respiratory Foundation
  • the Jalmari and Rauha Ahokas Foundation
  • Research Director of Kuopio University Hospital
  • the state subsidy of Kuopio University Hospital
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Keywords
idiopathic pulmonary fibrosis, cigarette smoking, smoking status, survival, comorbidities, cardiovascular disease, chronic obstructive pulmonary disease, lung cancer, insulin use, former smokers, disease progression
MeSH terms
Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Retrospective Studies, Smoking, Comorbidity, Survival Rate, Idiopathic Pulmonary Fibrosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis. https://app.cochat.ai/papers/10.1186/s12931-017-0642-6
The paper
Kärkkäinen, M., Kettunen, H.-P., Nurmi, H., Selander, T., Purokivi, M., & Kaarteenaho, R. (2017). Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis. Respiratory Research. https://doi.org/10.1186/s12931-017-0642-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.